[Federal Register Volume 67, Number 115 (Friday, June 14, 2002)]
[Notices]
[Pages 40930-40931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15014]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30DAY-34-02]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 498-1210. Send written 
comments to CDC, Desk Officer, Human Resources and Housing Branch, New 
Executive Office Building, Room 10235, Washington, DC 20503. Written 
comments should be received within 30 days of this notice.
    Proposed Project: The Development and Testing of a Tool to Assess 
the Public's Perception about People with

[[Page 40931]]

Epilepsy--New--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC). About 2.3 million people in the U.S. have some form of epilepsy, 
a neurological condition in which the brain's normal electrical 
functions may be interrupted with bursts of electrical impulses. 
Epilepsy affects people of all ages, but particularly the very young 
and the elderly. Persons with chronic or disabling health conditions 
like epilepsy face myriad challenges including establishing and 
following a treatment regimen, developing and enacting self-management 
plans, and finding social support.
    Compounding these challenges are the reactions and beliefs of 
people with whom they interact. The stigma and perceived stigma of 
their health condition can lead to problems with self-management of 
their disease and further morbidity.
    The goal of this project is to develop a valid and reliable 
measurement tool to assess the public's perception of epilepsy and 
seizure disorders. This tool may shed light on the challenges in the 
social environment confronted by people with epilepsy and by their care 
givers. It will help gauge the climate of the general public and guide 
future epilepsy interventions. Once the tool has been developed, 
reliability and validity tests need to be conducted to ensure it is a 
scientifically rigorous instrument.
    The goals of the proposed data collection are to assess the 
instrument's:
     Internal consistency--how well different measures of the 
same construct reflect that construct
     Concurrent validity--the degree to which an operation is 
able to predict the behavior it purports to predict
     Construct validity--the extent to which an operation 
measures only the defined construct and not other constructs
     Test-retest reliability--the stability of the measure over 
time
    A random digit dial survey will be conducted with 750 respondents 
via computer assisted telephone interviewing (CATI) techniques. The 
number of respondents is sufficient to be generalizable to the U.S. 
population and to perform data reduction techniques such as factor 
analysis. Of the 750 respondents, 100 will be called back within two 
weeks to assess test-retest reliability. The total annual burden for 
this data collection is 318 hours.

----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden/
                             Survey                                  Number of      responses/     response  (in
                                                                    respondents     respondent        hours)
----------------------------------------------------------------------------------------------------------------
Screening Calls.................................................             900               1            2/60
Completed Interviews............................................             750               1           20/60
Reliability Test-Screening......................................             120               1            2/60
Reliability Test-Completed Interviews...........................             100               1           20/60
----------------------------------------------------------------------------------------------------------------


    Dated: June 6, 2002.
Julie Fishman,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-15014 Filed 6-13-02; 8:45 am]
BILLING CODE 4163-18-P